Real-world Effectiveness and Safety of Bulevirtide Monotherapy for Up to 96 Weeks in Patients with HDV-related Cirrhosis
Elisabetta Degasperi,Maria Paola Anolli,Mathias Jachs,Thomas Reiberger,Victor De Ledinghen,Sophie Metivier, Gianpiero D’Offizi, Francesco di Maria,Christoph Schramm,Hartmut Schmidt,Caroline Zöllner,Frank Tacke,Christopher Dietz-Fricke,Heiner Wedemeyer,Margarita Papatheodoridi,George Papatheodoridis,Ivana Carey,Kosh Agarwal,Florian Van Bömmel,Maurizia R. Brunetto Journal of Hepatology（2025）
关键词
Bulevirtide,HDV,Entry inhibitor,HDV RNA,cirrhosis,virological response
AI 理解论文
溯源树
样例
